Hofseth BioCare ASA 2024 SR
The report highlights Hofseth BioCare's commitment to circularity by upcycling salmon off-cuts into high-value nutritional products. In 2024, the company achieved an 18% increase in raw material utilization and received an EcoVadis bronze medal, placing it in the top 35% of assessed companies. Key developments included expanding Scope 3 GHG reporting, establishing a Working Environment Committee, and maintaining a 50% female board representation. The company also advanced clinical research on its core ingredients, ProGo, OmeGo, and NT-II, while planning a new hydrolysis plant at Berkåk to support local growth.
Company: Hofseth BioCare ASA
Sector: Health Care
Country: Norway
Year: 2024
Type: SR
Pages: 38
Hofseth BioCare ASA
ESG Report
The report highlights Hofseth BioCare's commitment to circularity by upcycling salmon off-cuts into high-value nutritional products. In 2024, the company achieved an 18% increase in raw material utilization and received an EcoVadis bronze medal, placing it in the top 35% of assessed companies. Key developments included expanding Scope 3 GHG reporting, establishing a Working Environment Committee, and maintaining a 50% female board representation. The company also advanced clinical research on its core ingredients, ProGo, OmeGo, and NT-II, while planning a new hydrolysis plant at Berkåk to support local growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Apr 11, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees